Table 7 Inhalability adjusted particle penetration (50% cut-point) through respiratory tract regions
From: Thoracic and respirable particle definitions for human health risk assessment
V daily(%-tile) | Normal | Gradual | ||||||
|---|---|---|---|---|---|---|---|---|
Augmenter | Mouth-breather | Augmenter | Oral only | |||||
P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | |
Male | ||||||||
5% | 2.92 a | 2.72 | 4.97 | 4.24 | 3.55 | 3.22 | 8.24 | 6.38 |
95% CI | (1.71–4.90) | (1.64–4.26) | (3.09–7.66) | (2.81–5.85) | (2.11–5.82) | (2.00–4.85) | (5.66–11.4) | (4.89–7.59) |
50% | 2.44 | 2.30 | 4.93 | 4.21 | 3.33 | 3.02 | 7.52 | 5.90 |
95% CI | (1.43–4.12) | (1.37–3.67) | (3.11–7.51) | (2.84–5.67) | (1.99–5.43) | (1.87–4.54) | (5.12–10.5) | (4.50–6.98) |
95% | 2.14 | 2.02 | 4.92 | 4.22 | 3.15 | 2.88 | 7.14 | 5.71 |
95% CI | (1.25–3.62) | (1.20–3.29) | (3.13–7.44) | (2.87–5.64) | (1.89–5.15) | (1.78–4.36) | (4.84–10.1) | (4.32–6.77) |
Female | ||||||||
5% | 2.90 | 2.70 | 4.22 | 3.72 | 3.08 | 2.85 | 8.06 | 6.23 |
95% CI | (1.70–4.87) | (1.63–4.20) | (2.56–6.73) | (2.38–5.34) | (1.81–5.13) | (1.73–4.40) | (5.53–11.2) | (4.78–7.41) |
50% | 2.41 | 2.26 | 4.36 | 3.81 | 2.89 | 2.67 | 7.35 | 5.77 |
95% CI | (1.41–4.06) | (1.35–3.60) | (2.70–6.80) | (2.50–5.29) | (1.71–4.79) | (1.63–4.12) | (5.00–10.3) | (4.39–6.83) |
95% | 2.10 | 1.99 | 4.46 | 3.89 | 2.72 | 2.52 | 7.00 | 5.60 |
95% CI | (1.23–3.55) | (1.18–3.23) | (2.80–6.87) | (2.58–5.33) | (1.61–4.42) | (1.53–3.93) | (4.74–9.91) | (4.22–6.66) |
Child-B b | ||||||||
5% | 2.76 | 2.60 | 4.22 | 3.73 | 4.21 | 3.72 | 7.73 | 6.20 |
95% CI | (1.62–4.64) | (1.56–4.11) | (2.56–6.69) | (2.39–5.38) | (2.56–6.68) | (2.39–5.37) | (5.28–10.8) | (4.65–7.52) |
50% | 2.24 | 2.13 | 4.27 | 3.75 | 3.99 | 3.54 | 7.05 | 5.63 |
95% CI | (1.31–3.79) | (1.27–3.44) | (2.65–6.66) | (2.46–5.20) | (2.45–6.30) | (2.28–5.01) | (4.77–9.98) | (4.25–6.74) |
95% | 1.89 | 1.80 | 4.25 | 3.71 | 3.91 | 3.45 | 6.56 | 5.21 |
95% CI | (1.10–3.21) | (1.07–2.96) | (2.67–6.56) | (2.47–4.99) | (2.42–6.12) | (2.25–4.78) | (4.42–9.37) | (3.96–6.15) |
Child-A c | ||||||||
5% | 3.87 | 3.52 | 5.40 | 4.62 | 5.39 | 4.61 | 7.73 | 6.20 |
95% CI | (2.28–6.36) | (2.17–5.27) | (3.34–8.32) | (3.07–6.32) | (3.34–8.31) | (3.06–6.31) | (5.28–10.8) | (4.65–7.52) |
50% | 3.15 | 2.92 | 5.20 | 4.44 | 4.96 | 4.28 | 7.05 | 5.63 |
95% CI | (1.85–5.29) | (1.77–4.49) | (3.26–7.96) | (3.00–5.88) | (3.09–7.66) | (2.86–5.75) | (4.77–9.98) | (4.25–6.74) |
95% | 2.66 | 2.49 | 5.00 | 4.26 | 4.73 | 4.07 | 6.56 | 5.21 |
95% CI | (1.56–4.47) | (1.50–3.91) | (3.16–7.64) | (2.92–5.51) | (2.96–7.29) | (2.74–5.39) | (4.42–9.37) | (3.96–6.15) |